Manfridi A, Clavenna A, De Simoni M G
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Neurosci Lett. 1992 May 11;139(1):69-72. doi: 10.1016/0304-3940(92)90860-a.
Sertraline, a potent and selective serotonin uptake inhibitor, was used to analyze the changes occurring in the serotonin system after uptake inhibition in vivo. Sertraline (11 mg/kg) lowered extracellular 5-hydroxyindolacetic acid (5-HIAA), measured in rat hippocampus by in vivo voltammetry, for about 3 h. The interaction between sertraline and drugs known to interfere with the release or uptake of serotonin (L-5-hydroxytryptophan (5-HTP), d-norfenfluramine and tianeptine) was then studied. The sertraline-induced decrease in extracellular 5-HIAA was related to the inhibition of uptake.
舍曲林是一种强效且选择性的血清素摄取抑制剂,用于分析体内摄取抑制后血清素系统发生的变化。舍曲林(11毫克/千克)可使通过体内伏安法在大鼠海马体中测得的细胞外5-羟吲哚乙酸(5-HIAA)降低约3小时。随后研究了舍曲林与已知干扰血清素释放或摄取的药物(L-5-羟色氨酸(5-HTP)、右旋诺氟拉明和噻奈普汀)之间的相互作用。舍曲林引起的细胞外5-HIAA降低与摄取抑制有关。